Pharmaceuticals
3 Turkey Stocks That Should Have Better Years in 2023
The prospects for this trio are better than in the current year, which has been rough on all three.
Teva Pharmaceutical Is Bottoming: Here's My Strategy
Let's check the charts of this generic drug maker.
Vertex Pharmaceuticals: Is the Recovery Story Intact?
Let's check out the charts to see if the rally can still push higher.
GSK Plc Gets a Belated Fundamental Downgrade
Here's what to expect in the weeks and months ahead.
Halozyme Therapeutics Earns a Second Price Target as Its Charts Improve
The biotechnology company is seeing heavier trading volume in its stock on days when its shares trade higher.
It's Time to Reexamine Eli Lilly's Charts
Here's where resistance may develop.
Checking on Amylyx Pharmaceuticals Ahead of Earnings
This is somewhat of a speculative name.
2 Beaten-Down Value Stocks That Keep Struggling to Get Off the Mat
One is a footwear company and the other a drugmaker that was this writer's "top pick" for the balance of the year last spring.
So Much for a Red Wave, Crypto Rescue, Weighing Obesity Drugs, US-Taiwan Talk
Plus, the Treasury yield spread moved in the wrong direction Tuesday, signaling possible economic hardship ahead.
Here's My Formula for Investing in Gilead Sciences
The stock reached its price target, so now what do the charts say?